INS and pancreatic neoplasm: Subsequently, we identified positive crosstalk between insulin/IGFI receptors and GPCR signaling systems in pancreatic cancer cells, leading to mTORC1 signaling and ERK activation, and synergistic stimulation of DNA synthesis and cell proliferation [20]–[22].